DBV Technologies SA (DBVT.OQ)
15 Dec 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|2015||Chairman of the Board, Chief Executive Officer|
|2015||Chief Operating Officer|
|2015||Chief Scientific Officer|
|Director of Research|
|Director of Corporate Communication & Business Development|
- BRIEF-DBV Technologies says Viaskin Peanut study demonstrates good tolerance and safety of product
- BRIEF-DBV Technologies says announces positive results for phase III trial regarding Viaskin Peanut allergy treatment
- French and Benelux stocks-Factors to watch on Nov 15
- BRIEF-DBV Technologies announces positive data from Phase IIb trial and long-term study of Viaskin Peanut
- BRIEF-DBV Technologies reports at Sept. 30 cash position of 170.5 million euros